Orencia denied by insurance? Appeal and win.
A denial for Orencia is the start of a process, not the end of it. Orencia is most often denied because the plan applies step therapy that requires you to first try and fail a preferred TNF inhibitor, or because the prior authorization criteria, such as a documented conventional DMARD trial and recent tuberculosis screening, were not included in the original request. Appeals frequently succeed when the submission maps your specific history directly to the plan's own written criteria and supplies the documentation the first request was missing.
Reviewed by the Apellica Appeals Team · Updated June 2026
Carrier names and logos are trademarks of their respective owners. Apellica is independent and not affiliated with any insurance carrier or carrier's appeal program.
Orencia (abatacept) is FDA approved to treat moderately to severely active rheumatoid arthritis in adults, where it can reduce symptoms, slow joint damage, and improve physical function. It is also approved for active psoriatic arthritis in adults and for polyarticular juvenile idiopathic arthritis in children 2 years and older. It may be used alone or in combination with non-biologic DMARDs such as methotrexate, but it is not intended to be combined with other biologics or JAK inhibitors.
Why Orencia gets denied
- Step therapy: the plan requires a documented trial and failure of one or more preferred biologics, typically a TNF inhibitor such as Humira or its biosimilar, before it will cover Orencia.
- Conventional DMARD requirement not documented: the plan wants evidence of an adequate trial (often at least 3 months) and inadequate response to a non-biologic DMARD such as methotrexate, and that history was missing or incomplete.
- Prior authorization criteria gaps: missing diagnosis confirmation, disease activity measures, or required baseline labs such as tuberculosis and hepatitis B screening before starting therapy.
- Site-of-care or formulary status: the IV infusion is denied because it was not scheduled at a plan-approved site of care, or the drug is non-formulary or placed on a tier requiring an exception.
What a winning appeal includes
- A confirmed diagnosis with the matching ICD-10 code (for example M05 or M06 for rheumatoid arthritis, L40.5/M07 for psoriatic arthritis, or M08 for juvenile idiopathic arthritis) and objective disease activity documentation.
- A clear record of prior therapies tried and failed, including specific DMARDs and any biologics, with dates, duration, and the reason each was stopped (inadequate response, intolerance, or contraindication).
- A letter of medical necessity that quotes the plan's own coverage criteria and maps each requirement to the patient's documented history point by point.
- Required drug-specific documentation, including a negative or treated tuberculosis screen within the past 12 months and hepatitis B evaluation, plus a statement on contraindications to preferred alternatives where applicable.
How we approach the appeal
First identify which type of denial you received, because the path differs. If the drug is non-formulary or on a high tier, request a formulary or tier exception; if it is a step therapy or clinical denial, file a prior authorization appeal or a medical necessity appeal. Pull the plan's published Orencia policy, quote its exact criteria back to it (for example its DMARD trial language, its preferred-biologic step requirements, and its TB and hepatitis B screening conditions), and show in writing that each one is met or that an exception applies because preferred agents failed, were not tolerated, or are contraindicated.
Orencia appeal letter template
Copy this Orencia appeal letter, fill in the brackets, and send it within your deadline. It is built on what overturns T-cell costimulation modulator (selective costimulation modulator), a biologic disease-modifying antirheumatic drug (DMARD) denials.
[Date] [Your name] · Member ID [ID] · Rx claim # [#] [Insurer or PBM] - Appeals Department Re: Appeal of Orencia denial I am appealing the denial of Orencia (abatacept). I request that the denial be overturned and Orencia approved. 1. The denial. [Insurer] denied Orencia stating, verbatim: "[paste the exact denial reason from your letter]." 2. Medical necessity. Orencia is medically necessary for my condition. First identify which type of denial you received, because the path differs. If the drug is non-formulary or on a high tier, request a formulary or tier exception; if it is a step therapy or clinical denial, file a prior authorization appeal or a medical necessity appeal. Pull the plan's published Orencia policy, quote its exact criteria back to it (for example its DMARD trial language, its preferred-biologic step requirements, and its TB and hepatitis B screening conditions), and show in writing that each one is met or that an exception applies because preferred agents failed, were not tolerated, or are contraindicated. 3. Step-therapy or formulary exception (if that was the reason): I have tried and failed [preferred drug(s)], with pharmacy records attached, or the preferred alternative is contraindicated because [reason]. I request a formulary or step-therapy exception. 4. My request. Approve Orencia within the timeframe required by law. If the denial is upheld, please provide the specific criteria used, the reviewing clinician's credentials, and external-review instructions. Attached: prescriber letter of medical necessity, pharmacy and prior-trial records, and supporting clinical notes. Sincerely, [Your name]
Want it built and filed for you? Use the free generator, or have Apellica do it.
Internal appeals: 30 days pre-service, 60 days post-service, 72 hours urgent. File within 180 days of the denial.
$0 upfront. We assess fit first, then build and file the appeal for you.
- · The denial letter and your Explanation of Benefits (EOB)
- · Insurance ID, plan name, and the claim or prior-authorization number
- · Diagnosis with ICD-10 code and the prescriber's clinical notes
- · A record of treatments already tried and how they worked
Appealing a Orencia denial by insurer
The path depends on who manages your benefit. The most common:
Coverage runs through the pharmacy benefit. Appeal the coverage determination and, when the drug is non-formulary, file a formulary or tier exception with a provider attestation that covered alternatives are unsuitable.
Publishes detailed prior-authorization criteria. A denial usually means a criterion was not documented. Appeal through a coverage review, with a formulary exception for excluded drugs.
Administers many UnitedHealthcare and employer plans. Appeals and exceptions follow the plan's published PA criteria; expedited review exists for urgent cases.
Internal appeal first, then independent external review. Pre-service decisions are generally made within 30 days, urgent within 72 hours.
Internal appeals and external review; pharmacy denials often route through OptumRx criteria.
Independent state plans, so criteria vary. Match the appeal to your specific BCBS plan, internal appeal first, then external review.
Frequently asked questions
My plan says I have to try Humira first. Can I still get Orencia approved?
Often yes. Step therapy can usually be overridden when you document that the required preferred biologic was already tried and failed, caused side effects you could not tolerate, or is medically contraindicated for you. If your rheumatologist believes a TNF inhibitor is not appropriate for your situation, that clinical rationale should be stated clearly in the letter of medical necessity, with supporting records.
Why does my insurer want my tuberculosis and hepatitis B test results before approving Orencia?
Because Orencia affects the immune system, screening for latent tuberculosis and for hepatitis B before starting therapy is part of safe prescribing and is built into most plans' coverage criteria. Including a tuberculosis screen from within the past 12 months and a hepatitis B evaluation with your request removes a common reason for denial and avoids back-and-forth delays.
My Orencia IV infusion was denied even though the drug itself is covered. What happened?
This is usually a site-of-care issue rather than a coverage issue. Many plans require infusions to be given at a plan-approved location, such as a specific infusion center or at home, instead of a hospital outpatient setting. Confirming the approved site of care, or appealing with a medical reason your prescribed location is necessary, typically resolves it. The subcutaneous (self-injected) form may be an alternative if appropriate for you.
Orencia denied? We fight it for you.
$0 upfront. Two-minute intake. We confirm fit and reply within one business day with the right path for your situation.
Start Your AppealThis page provides general information about appeal strategy. It is not legal or medical advice. Apellica is not a law firm. Outcomes depend on documentation, plan terms, and timing.